Maravai LifeSciences Holdings, Inc. MRVI
Set alert
As of Nov 2, 3:02 PM ET
- YTD
- +125.23%
- 1 year
- +133.12%
- Open
- 7.81
- Prev close
- 7.81
- Mkt cap
- 2.72B
- Vol
- 1.20M
- Avg vol
- 3.18M
- EPS
- -0.53
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.23
- High
- 7.99
- Forward P/E
- -77.59
- Beta
- 0.54
- Short ratio
- 4.94
- Inst. own
- 99.16%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 7.51
- 200-d avg
- 5.22
- 1y target
- 8.50
5D chart
Signals (87)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 2:50 PM | 12 minutes ago |
| RSI: Oversold | Nov 2, 2:30 PM | 32 minutes ago |
| RSI: Oversold | Nov 2, 2:00 PM | 1 hour ago |
| MACD: Sell Signal | Nov 2, 1:45 PM | 1 hour ago |
| SMA: Bearish | Nov 2, 1:30 PM | 1 hour ago |
| SMA: Bearish | Nov 2, 1:15 PM | 1 hour ago |
| SMA: Bearish | Nov 2, 1:15 PM | 1 hour ago |
| SMA: Bullish | Nov 2, 12:35 PM | 2 hours ago |
| MACD: Buy Signal | Nov 2, 12:05 PM | 2 hours ago |
| RSI: Oversold | Nov 2, 11:50 AM | 3 hours ago |
| RSI: Oversold | Nov 2, 10:50 AM | 4 hours ago |
| SMA: Bearish | Nov 2, 9:35 AM | 5 hours ago |
| MACD: Sell Signal | Nov 2, 9:35 AM | 5 hours ago |
| SMA: Bullish | Oct 30, 2:55 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:35 PM | 3 days ago |
| SMA: Bearish | Oct 30, 2:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 1:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:20 PM | 3 days ago |
| RSI: Oversold | Oct 30, 1:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 3 days ago |
| RSI: Oversold | Oct 30, 11:40 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 11:10 AM | 3 days ago |
| SMA: Bearish | Oct 30, 10:50 AM | 3 days ago |
| SMA: Bullish | Oct 30, 10:45 AM | 3 days ago |
| RSI: Oversold | Oct 30, 10:00 AM | 3 days ago |
| RSI: Oversold | Oct 30, 9:50 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 9:30 AM | 3 days ago |
| RSI: Overbought | Oct 29, 3:50 PM | 4 days ago |
| SMA: Bullish | Oct 29, 3:25 PM | 4 days ago |
| SMA: Bearish | Oct 29, 2:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 29, 2:20 PM | 4 days ago |
| RSI: Oversold | Oct 29, 1:45 PM | 4 days ago |
| SMA: Bullish | Oct 29, 1:00 PM | 4 days ago |
| MACD: Sell Signal | Oct 29, 11:55 AM | 4 days ago |
| SMA: Bearish | Oct 29, 11:50 AM | 4 days ago |
| MACD: Buy Signal | Oct 29, 11:20 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:45 AM | 4 days ago |
| SMA: Bullish | Oct 29, 10:40 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 4 days ago |
| MACD: Sell Signal | Oct 29, 10:05 AM | 4 days ago |
| SMA: Bearish | Oct 29, 10:00 AM | 4 days ago |
| SMA: Bullish | Oct 29, 9:50 AM | 4 days ago |
| SMA: Bearish | Oct 29, 9:45 AM | 4 days ago |
| RSI: Overbought | Oct 29, 9:35 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:35 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:45 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:25 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 2:20 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 2:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 28, 2:10 PM | 5 days ago |
| SMA: Bearish | Oct 28, 2:05 PM | 5 days ago |
| SMA: Bullish | Oct 28, 2:00 PM | 5 days ago |
| SMA: Bearish | Oct 28, 1:45 PM | 5 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 5 days ago |
| MACD: Buy Signal | Oct 28, 12:45 PM | 5 days ago |
| SMA: Bullish | Oct 28, 12:40 PM | 5 days ago |
| SMA: Bearish | Oct 28, 11:30 AM | 5 days ago |
| SMA: Bearish | Oct 28, 11:10 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:40 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:20 AM | 5 days ago |
| MACD: Sell Signal | Oct 28, 10:20 AM | 5 days ago |
| SMA: Bullish | Oct 28, 10:10 AM | 5 days ago |
| SMA: Bearish | Oct 28, 10:05 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:50 AM | 5 days ago |
| RSI: Overbought | Oct 28, 9:35 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 4:00 PM | 6 days ago |
| SMA: Bullish | Oct 27, 3:50 PM | 6 days ago |
| SMA: Bullish | Oct 27, 3:50 PM | 6 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 6 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 6 days ago |
| SMA: Bullish | Oct 27, 3:40 PM | 6 days ago |
| SMA: Bullish | Oct 27, 3:40 PM | 6 days ago |
| SMA: Bearish | Oct 27, 3:35 PM | 6 days ago |
| SMA: Bullish | Oct 27, 1:55 PM | 6 days ago |
| RSI: Overbought | Oct 27, 1:55 PM | 6 days ago |
| SMA: Bearish | Oct 27, 1:35 PM | 6 days ago |
| RSI: Overbought | Oct 27, 1:10 PM | 6 days ago |
| SMA: Bullish | Oct 27, 12:45 PM | 6 days ago |
| RSI: Overbought | Oct 27, 11:35 AM | 6 days ago |
| RSI: Overbought | Oct 27, 11:05 AM | 6 days ago |
News
2 weeks ago businesswire.com
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its…
2 weeks ago benzinga.com
Full Transcript: Maravai LifeSciences Q2 2026 Earnings Call
Maravai LifeSciences (NASDAQ:MRVI) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is…
4 weeks ago defenseworld.net
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Has Average Price Target of $6.83
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI - Get Free Report) has received an average recommendation of "Hold" from the five ratings firms that are covering the stock, Marketbeat reports. One…
1 month ago businesswire.com
TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, today announced it has…
-
1 month ago benzinga.com
UBS Maintains Neutral on Maravai LifeSciences, Raises Price Target to $8
UBS analyst Dan Brennan maintains Maravai LifeSciences (NASDAQ:MRVI) with a Neutral and raises the price target from $2.5 to $8.
2 months ago seekingalpha.com
Maravai LifeSciences: The Post-COVID Reset Has Created An RNA Consumables Flywheel
Maravai (MRVI) is evolving into an integrated supplier for the in vitro transcription (IVT) RNA workflow, embedding products across the customer lifecycle. Q2 2026 marked a profitability inflection,…
2 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 34.0% to $1.26 during Thursday's regular session. The company's market cap stands at $125.2 million. BioVie (NASDAQ:BIVI) stock…
2 months ago benzinga.com
Deere, Coinbase Global, Nordson And Other Big Stocks Moving Higher On Wednesday
Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX, SCSC, BTBT, MRVI, HIVE, AHG, TEM, MARA, LB also gain.
2 months ago benzinga.com
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting strong Q4 results and positive sales guidance.
2 months ago defenseworld.net
Dimensional Fund Advisors LP Boosts Holdings in Maravai LifeSciences Holdings, Inc. $MRVI
Dimensional Fund Advisors LP boosted its holdings in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) by 64.8% in the undefined quarter, according to its most recent Form 13F filing with…
2 months ago defenseworld.net
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down – Here’s Why
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI - Get Free Report) shares gapped down before the market opened on Friday. The stock had previously closed at $6.25, but opened at $5.60. Maravai…
-
2 months ago benzinga.com
Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $6.5
Wells Fargo analyst Evan Stampler maintains Maravai LifeSciences (NASDAQ:MRVI) with a Overweight and raises the price target from $5.5 to $6.5.
2 months ago seekingalpha.com
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript
2 months ago defenseworld.net
Maravai LifeSciences Q2 Earnings Call Highlights
Maravai LifeSciences (NASDAQ: MRVI) reported second-quarter 2026 revenue growth and a sharp improvement in adjusted profitability, while maintaining its full-year revenue outlook and raising its…
2 months ago marketbeat.com
Maravai LifeSciences Q2 Earnings Call Highlights
Maravai LifeSciences NASDAQ: MRVI reported second-quarter 2026 revenue growth and a sharp improvement in adjusted profitability, while maintaining its full-year revenue outlook and raising its…
2 months ago zacks.com
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates
Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.08 per share a year…
-
2 months ago benzinga.com
Maravai LifeSciences Affirms FY2026 Sales Guidance of $205.000M-$215.000M vs $210.433M Est
Maravai LifeSciences (NASDAQ:MRVI) affirms FY2026 sales outlook from $205.000 million-$215.000 million to $205.000 million-$215.000 million vs $210.433 million estimate.
2 months ago businesswire.com
Maravai LifeSciences Reports Second Quarter 2026 Financial Results
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported…
3 months ago businesswire.com
Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its…
-
3 months ago benzinga.com
Maravai LifeSciences' TriLink BioTechnologies Obtains New Patent From The China National Intellectual Property Administration, Patent Number ZL 2025 1 1246578.X
TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ:MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National…
3 months ago businesswire.com
TriLink BioTechnologies® Further Strengthens Global IP Position with Newly Issued Patent in China for CleanCap® Capping Technology
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new…
4 months ago gurufocus.com
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
TriLink, part of Maravai LifeSciences (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to h
4 months ago businesswire.com
TriLink Opens GMP Enzyme Manufacturing Facility, Enabling Integrated IVT Supply from R&D to Commercial Scale
JUPITER, Fla.--(BUSINESS WIRE)--TriLink, part of Maravai LifeSciences® (NASDAQ: MRVI), today announced the opening of its GMP enzyme manufacturing facility in Jupiter, Florida, designed to help RNA…
5 months ago businesswire.com
Maravai LifeSciences Announces Refinancing of Credit Agreement, Extending Maturity to 2032
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that…
5 months ago gurufocus.com
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that
5 months ago businesswire.com
Maravai LifeSciences To Attend The Jefferies Global Healthcare Conference
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that the Company…
5 months ago seekingalpha.com
Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable
Maravai LifeSciences Holdings, Inc. is upgraded to Buy, driven by operational restructuring, improved guidance, and sector recovery. MRVI raised 2026 revenue guidance to $205–$215M and adjusted…
5 months ago seekingalpha.com
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript
-
5 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
5 months ago benzinga.com
Wells Fargo Maintains Overweight on Maravai LifeSciences, Raises Price Target to $5.5
Wells Fargo analyst Brandon Couillard maintains Maravai LifeSciences (NASDAQ:MRVI) with a Overweight and raises the price target from $4.5 to $5.5.
5 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
-
5 months ago benzinga.com
Maravai LifeSciences Raises FY2026 Sales Guidance from $200.000M-$210.000M to $205.000M-$215.000M vs $204.933M Est
Maravai LifeSciences (NASDAQ:MRVI) raises FY2026 sales outlook from $200.000 million-$210.000 million to $205.000 million-$215.000 million vs $204.933 million estimate.
-
5 months ago benzinga.com
Maravai LifeSciences Q1 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $65.837M Beat $53.046M Estimate
Maravai LifeSciences (NASDAQ:MRVI) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.05) by 120 percent. This is a 112.5 percent increase over losses of…
8 months ago benzinga.com
Earnings Scheduled For February 25, 2026
Earnings Scheduled For February 25, 2026
12 months ago benzinga.com
Earnings Scheduled For November 6, 2025
Earnings Scheduled For November 6, 2025
-
1 year ago benzinga.com
Earnings Scheduled For August 11, 2025
Earnings Scheduled For August 11, 2025
1 year ago benzinga.com
Trump Media & Technology Group, BitFuFu, Mobileye Global And Other Big Stocks Moving Higher On Tuesday
Trump Media & Technology Group, BitFuFu, Mobileye Global And Other Big Stocks Moving Higher On Tuesday
-
1 year ago benzinga.com
Earnings Scheduled For February 25, 2025
Earnings Scheduled For February 25, 2025
1 year ago benzinga.com
Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings
Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
-
2 years ago benzinga.com
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
-
2 years ago benzinga.com
BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session.
-
2 years ago benzinga.com
Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results.
-
2 years ago benzinga.com
Why AXT Shares Are Trading Higher By Around 36%; Here Are 20 Stocks Moving Premarket
Shares of AXT, Inc. (NASDAQ: AXTI) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results.
-
2 years ago benzinga.com
Earnings Scheduled For February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
-
2 years ago benzinga.com
Tech Drags On Wall Street As 2024 Kicks Off; Dollar and Treasury Yields Surge: What's Driving Markets Tuesday?
Wall Street kicked off 2024 on a weaker note, with the S&P 500 dipping by 0.5%, and the Nasdaq 100 experiencing a 1.4% decline in midday trading in New York.
-
2 years ago benzinga.com
US Stocks Set To Snap Winning Streak, Treasuries Rally, Oil Tumbles: What's Driving Markets Wednesday?
U.S. stocks experienced a drop as of midday trading in New York, potentially ending a prolonged streak of consecutive daily gains as investors evaluate the economic outlook. Commodity prices…
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session